Tag:

Wegovy

Amazon enters weight-loss drug market with new GLP-1 service

Amazon has officially stepped deeper into the booming weight-loss drug market, launching a new GLP-1 treatment program designed to make obesity care faster, more convenient, and more accessible for patients.

22 Apr 2026-11:22
Novo Nordisk teams up with OpenAI on AI drugs

Novo Nordisk is turning to artificial intelligence to accelerate drug development, announcing a major partnership with OpenAI as competition intensifies in the booming weight-loss market.

14 Apr 2026-10:05
Novo Nordisk cuts Wegovy prices in US plan

Novo Nordisk is launching discounted subscription plans for its weight-loss drug Wegovy in the United States, as competition intensifies in the fast-growing obesity treatment market.

31 Mar 2026-15:58
India floods market with low-cost copies of Novo’s drugs

At least six Indian pharmaceutical companies have introduced low-cost versions of Novo Nordisk’s (Novo Nordisk) blockbuster diabetes drug Ozempic and weight-loss medication Wegovy over the weekend, offering treatment at prices up to 70% lower than the original.

23 Mar 2026-20:11
Novo Nordisk, Hims to sell obesity drugs together

Danish drugmaker Novo Nordisk plans to sell its obesity treatments through the platform of Hims & Hers Health, ending a dispute between the two firms that recently escalated into a legal battle.

07 Mar 2026-09:31
Novo to sue over HIMS' compounded Wegovy pill

05 Feb 2026-21:34
Novo Nordisk shares rise on strong Wegovy U.S. scripts

Novo Nordisk shares jumped over 5% on Friday, hitting levels not seen since October, following “encouraging” early U.S. prescription data for its Wegovy weight-loss pill.

16 Jan 2026-16:30
Novo Nordisk launches Wegovy pill, sparks US price war

Danish pharmaceutical giant Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight-loss drug, Wegovy, in the United States, intensifying a price war in the sector.

06 Jan 2026-11:11
Novo Nordisk fights to keep medicaid coverage for weight-loss drug Wegovy

Pharmaceutical giant Novo Nordisk is fighting to maintain Medicaid coverage for its popular weight-loss drug Wegovy, as several U.S. states move to limit or end reimbursements due to rising costs and overwhelming demand.

21 Oct 2025-14:35
Chinese firms pivot to generics as U.S. weight-loss drug boom slows

Some Chinese pharmaceutical companies are shifting focus to producing generic versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound as U.S. demand for makeshift weight-loss drugs slows. Over the past two years, Chinese suppliers provided raw ingredients for more than a billion doses sold online by compounding pharmacies, fueled by telehealth services.

02 Sep 2025-16:53